支原体测试市场份额，规模，趋势，行业分析报告，由产品（仪器，套件和试剂，服务）;通过技术（PCR，ELISA，直接测定，间接测定，微生物培养技术，酶法）;通过申请;结束使用;按地区;分部预测，2020 - 2027年

报告摘要

The global mycoplasma testing market was valued at USD 628.2 million in 2019 and is expected to grow at a CAGR of 12.8% during the forecast period. Increasing cases of cell culture contamination, investments in research and development, and the introduction of novel technologies by key market players are the prominent factors responsible for market growth.

为了克服，市场的创新者在目前就业的细胞培养系统中的缺点已经开发出更快和准确的支原体测试系统。一种这样的系统包括由美国型培养物收集引入的基于核酸的技术（NAT），其允许在几分钟内进行细胞培养的支原体检测。

了解有关此报告的更多信息：request for sample pages

Industry Dynamics

Growth Drivers
Increasing research activities in the market by the pharmaceutical companies resulting in the adoption of newer technologies for the drug development processes. Significant investments by key companies have boosted mycoplasma testing market growth. For instance, in 2018, Boehringer announced to invest more than USD 259 million to establish new Biologicals Development Center (BDC) at its R&D site located in Germany. Merck also planned to make investments of USD 16 billion for its research and development activities. Such, huge spending on R&D is projected to scale up to significant developments, boosting the sale of mycoplasma testing products and services.

此外，一些政府组织的生物技术和制药部门市场上市场的研究活动主要是支持。例如，2019年4月，食品和药物管理局（FDA）宣布修改了与支原体污染物中的检测方法有关的法规。通过此类修正案，利益攸关方将采用保护措施，以实现可能的支原体污染。因此，政府资助对研究和开发活动的资金增加，促进了支原体测试产品的摄取。

Mycoplasma Testing Market Report Scope

The market is primarily segmented on the basis of product, technology, application, end-use, and region.

由产品	By Technology	通过申请	按地区
Instruments Kits & Reagents PCR Assays Nucleic Acid Detection Kits Stains 消除套件 标准与控制 Others 服务	PCR ELISA Direct Assay 间接测定 微生物培养技术 酶法	Cell Line Testing 病毒测试 生产细胞结束测试 Others	北美（美国，加拿大） 欧洲（法国，德国，英国，意大利，西班牙，荷兰，奥地利） 亚洲Pacific (Japan, China, India, Malaysia, Indonesia, South Korea) 拉丁美洲（巴西，墨西哥，阿根廷） 中东和非洲（沙特阿拉伯，阿联酋，以色列，南非）

了解有关此报告的更多信息：request for sample pages

Insight by Product

在产品的基础上，全球支原体测试行业分叉进入仪器，试剂和服务。2019年，套件分部占收入份额最大。在研究和其他应用中的支原体检测中持续使用消耗品主要负责此类市场分段增长。通过验证DNA片段的不同条带，PCR测定是使用凝胶电泳的最准确的检测技术。例如，基于日本的公司Takara Bio Inc.已经引入了PCR支原体套，以含有来自不同细胞系的培养细胞中的污染。

仪器市场部门预计将在研究期间注册利润丰厚的增长率。市场中自动化系统的不断增长的可用性负责此类高位市场的增长。例如，Bio-Rad实验室已经开发出基于PCR的CFX96触摸PCR检测系统。这是一种具有先进光学技术的灵活的PCR套件，可为多路复用和单方面反应提供可靠的服务。

应用洞察力

In 2019, the cell line testing market segment accounted for the largest share, owing to the number of research activities in细胞培养。细胞系测试在制药行业非常有用。生产细胞测试市场部门的结束预计将在预测期间表现出利润丰厚的市场增长。

药物发现和细胞收集技术领域越来越多的临床试验主要负责支原体测试市场的生长。它涉及使用转基因的mRNA测序，Southern印迹和遗传分析。因此，药物发现期间涉及的质量控制措施是诱导此类市场增长的主要因素。

技术洞察力

Based on the technology, the global mycoplasma testing industry is bifurcated into PCR, ELISA, direct assay, indirect assay, microbial culture techniques, and enzymatic methods. In 2019, the PCR market segment accounted for the largest share. PCR enables the detection of a multitude of mycoplasma species with high specificity and efficiency. Its rapid detection ability and user-friendliness are the major advantages offered by such a technique. For instance, LookOut Mycoplasma PCR, developed by Merck, facilitated the detection of Ureaplasma, Acholeplasma, and Mycoplasma contamination in cell cultures.

Direct assays anticipated showcasing significant market growth rate over the study period. Its rapid adoption owing to its high level of certainty is the key reason for mycoplasma testing industry growth. Moreover, the high demand for microbial culture for contaminations and other research activities in the pharmaceutical industry is also favoring the market segment’s growth prospects.

Geographic Overview

Geographically, the global mycoplasma testing industry is bifurcated into North America, Asia Pacific, Europe, Latin America, and Middle East & Africa. In 2019, the North America mycoplasma testing industry accounted for the largest revenue share, owing to investments by U.S.-based research institutions and higher healthcare spending to promote research activities in the pharmaceutical space. According to the estimates of the National Science Foundation, in 2019, the research and development activities in the U.S. showed a positive trend.

亚洲Pacific mycoplasma testing industry is anticipated to show a lucrative growth rate over the study period. This projected growth is due to a positive funding scenario and significant awareness in countries such as India. The government of India has introduced several strategic initiatives to facilitate research and development activities on a larger scale. Moreover, regulatory policies on the guidelines of biosafety levels are also projected to create opportunities in the long-term.

竞争洞察力

在市场上运营的突出球员包括Thermo Fisher Scientific，Inc。，Bionique Testratories，Inc。，Lonza Group Ltd.，Merck Kgaa，Roche Diagnostics，Meridian Bioscience，Inc。，查尔斯河实验室国际，Inc。，Savyon诊断，美国型文化收集，Invivogen，Promocell GmbH。

Few other market players in the industry include Nelson Laboratories Fairfield, Inc., Creative Bioarray, Mycoplasma Experience, Biological Industries Israel Beit Haemek Ltd., Norgen Biotek Corp., Biotools B & M Labs, S.A., GeneCopoeia, Inc., GenBio, Minerva Biolabs GmbH, Sartorius AG, Clongen Laboratories, Inc., and ScienCell Research Laboratories, Inc.